Navigation Links
Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
Date:5/18/2012

MORRISTOWN, N.J., May 18, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Ropinirole Extended-Release Tablets, 2mg, 4mg, 6mg, 8mg and 12mg, a generic equivalent to GlaxoSmithKline's Requip® XL.  Actavis believes this is the first generic Requip® XL available in the US.  Distribution of the product has commenced.  

Requip® XL, 2mg, 4mg, 6mg, 8mg and 12mg, had US sales of approximately $59.4 million for the 12 months ending December 31, 2011, according to IMS Health.   

Commenting on the new approval, Doug Boothe, CEO of Actavis in the US, said:

"The launch of Ropinirole Extended-Release Tablets showcases  Actavis' commitment in bringing new products to market to benefit both patients and payors. We are proud to play a part in lowering healthcare costs through the introduction of quality generic products."

 

Inquiries
David Myers, Jr.
Senior Manager, Products & Communications
Tel: (973)993-4503
E-mail: dmyers@actavis.com

About Actavis:
Actavis Inc. is the U.S. subsidiary of Actavis Group hf. Approximately one third of Actavis' sales are generated in North America, Actavis' single largest market. Based in Morristown, NJ, Actavis has U.S. manufacturing and packaging facilities in Elizabeth, NJ; a manufacturing facility in Lincolnton, NC; and research and development facilities in Owings Mills, MD and Sunrise, FL. Please visit www.actavis.us for more information.

Requip® XL is a registered trademark of a party other than Actavis.

Information in this press release may contain forward-looking statements with respect to the financial condition, results of operations and businesses of Actavis.  By their nature, forward-looking statements an
'/>"/>

SOURCE Actavis Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Actavis Receives Approval of Alprazolam ODT in the U.S.
2. Actavis Launches Generic Version of Flomax(R) In The U.S.
3. Sagent Pharmaceuticals and Actavis Enter Into Exclusive U.S. Development, Supply and Marketing Collaboration for a Portfolio of Specialty Injectable Pharmaceutical Products
4. Actavis Receives Approval of Bupropion HCl SR 100mg and 200mg in the U.S.
5. Actavis Receives FDA Approval of Atomoxetine HCl Capsules
6. Actavis Receives Approval of Losartan Potassium Tablets, USP in the U.S.
7. Actavis Receives Approval of Zolpidem Tartrate Extended-Release Tablets, USP 6.25mg CIV in the U.S. with 180-Day Marketing Exclusivity
8. Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/h
9. Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h
10. Actavis Receives Approval of Pantoprazole Sodium Delayed-Release Tablets, USP in the U.S.
11. Actavis Receives Approval of Valacyclovir Hydrochloride Tablets in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 InspireMD, Inc. ("InspireMD" ... in embolic protection stents, today announced new 6-month ... Elevation Reperfusion) trial demonstrating that the MGuard Embolic ... eluting stents in all-cause mortality in ST segment ... trial were presented at the InspireMD STEMI Symposium ...
(Date:5/23/2013)... and PARIS , May 23, ... a leading developer and manufacturer of precision guided therapy ... coronary and peripheral vascular disease, today announced preliminary results ... I ndependent S tenosis E valuation) ... trial session at EuroPCR 2013. These prospective results confirm ...
(Date:5/23/2013)... 22. Mai 2013 Ranbaxy ... Tochtergesellschaft von Daiichi Sankyo Co., Ltd. ... 22. Mai die Maßnahmen bekannt, die ... hat, um sich der Angelegenheiten der ... http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html ). Daiichi Sankyo ...
Breaking Medicine Technology:InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... , July 27 BioElectronics Corp. (Pink Sheets: ... its distribution partner for Japan , YesDTC Holdings, Inc. ... staff of the pending review by Japanese government medical device ... review will take place on Wednesday, July 28th . ...
... , July 27 Codexis, Inc. (Nasdaq: CDXS ) today ... Leadership Forum, August 8-10, 2010 in Vail, CO. ... presentation on August 10 at 8:30 am Mountain Time . ... www.codexis.com .   , , ...
Cached Medicine Technology:BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date 2Codexis to Present at the Pacific Crest Technology Leadership Forum 2
(Date:5/23/2013)... Netsmart today announced it is ranked ... information technology (HIT) providers for 2013. , The HCI 100 ... Healthcare Informatics magazine. Netsmart’s ranking of #49 is up ... growth is largely due to our commitment to helping organizations ... where resources are scarce, the demand for care is unprecedented ...
(Date:5/23/2013)... 2013 Applied PilotFish Healthcare Integration ... it has added support for the Direct Protocol to ... for Healthcare. In addition to the product’s already included ... and Web Services, it now offers support for the ... a specification of the Direct Project and ...
(Date:5/23/2013)... May 23, 2013 Aero Fulfillment Services, ... selected by NewWave Biosciences to be the sole fulfillment ... care professionals. , Brad Cole, CEO New Wave ... reasons including their central location, e-commerce experience with both ... and overall end-to-end solution that will expand as our ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Maintaining ... today launches its Summer Health Campaign. Kicking off in ... to offering a luxury bed for everyone and to ... overall health and well-being. , May is Better Sleep ... by the Better Sleep Council due to the Centers ...
(Date:5/23/2013)... Sika Sarnafil , the worldwide market ... Imperial Roof Systems of Iowa as the Recycling Project ... quality during the re-roofing of the SuperTarget retail store ... Sarnafil Elite contractor and one of Target’s Preferred Tier ... to sustainable building practices and they are a worthy ...
Breaking Medicine News(10 mins):Health News:Netsmart Named to Healthcare Informatics Top 100 List 2Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2Health News:DUXIANA®, Quality Bed Innovator, Celebrates Better Sleep Month and Launches Summer Health Campaign 2Health News:Sika Sarnafil Announces Recycling Project of the Year Winner 2
... 2008 Medical Records Institute (MRI),announces a new ... will be announced at the TEPR 2008 opening ... This new TEPR Award is the first ... their products meet a range of EMR medicolegal,requirements, ...
... 2008 Patients with genital and nipple piercings, also known ... initiate positive discussions about them, according to a new article ... Yet, too often, such discussions do not occur, even when ... to healthcare providers uneasiness over this increasingly common form of ...
... to observe in living cells a key step in the ... blocks that comprise DNA. Also called purines, the two ... which will be published in the 4 April 2008 issue ... that prevent cancer cells from replicating by interfering with their ...
... Circuit Court of Appeals today reversed a lower court,s ... decertifying,the nationwide class in Schwab., In its ruling, ... common proof, the class is not maintainable ... ", ... and agree with its,reasoning," said Martin L. Holton III ...
... Paisley Caves reveal genetic material in excrement linking New ... (HealthDay News) -- The oldest human DNA ever found ... Siberia or East Asia, according to an international team ... passed on maternally) was discovered in 14,300-year-old dried human ...
... in Pediatric, Oncology for Novel Approaches for Using X-ray Based ... ... April 3, 2008 Xoft consulting,medical director, Mark Carol, MD, has ... research focused on novel,approaches for using KV X-ray-based radiation therapy to ...
Cached Medicine News:Health News:Medical Records Institute Announces New TEPR Award for EMRs Best Meeting Medicolegal Requirements 2Health News:Enzyme complex could be key to new cancer treatments 2Health News:DNA Find in Oregon Is Oldest Yet Discovered in Americas 2Health News:Xoft Medical Director Recognized by Gotham Prize for Cancer Research 2Health News:Xoft Medical Director Recognized by Gotham Prize for Cancer Research 3
... are constructed of a patented ... polyvinyl acetal sponge. Each device ... to both surgeon and patient, ... firm enough to gently manipulate ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
Medicine Products: